跳到正文

IBO — Impact Biomedical Inc 机构持仓 · 2026年Q2

谁持有 Impact Biomedical Inc(IBO)?2026年Q2(报告期截至 2026-06-30)共有 20 家机构在 SEC 13F 申报中报告持有,合计 176.41 万美元。前几大持有机构:先锋领航(65.79 万美元)、Geode Capital Management, LLC(54.56 万美元)、道富(27.96 万美元)。

排名机构市值股数变动
1VANGUARD GROUP INC$657,9461.4M增持
2GEODE CAPITAL MANAGEMENT, LLC$545,5781.2M减持
3STATE STREET CORP$279,633607,897持平
4BlackRock, Inc.$119,575259,946持平
5NORTHERN TRUST CORP$108,319235,475减持
6CITADEL ADVISORS LLC$22,80149,567新建仓
7JANE STREET GROUP, LLC$11,28224,528新建仓
8TWO SIGMA INVESTMENTS, LP$7,90817,191减持
9Mason & Associates Inc$4,60010,000持平
10MORGAN STANLEY$4,2729,285增持
11UBS Group AG$1,1042,400减持
12Global Trust Asset Management, LLC$8361,818持平
13FMR LLC$134292增持
14WELLS FARGO & COMPANY/MN$103224持平
15Newbridge Financial Services Group, Inc.$4086持平
16Burk Holdings LLC$1227持平
17DANSKE BANK A/S$13持平
18Royal Bank of Canada$032持平
19Blue Trust, Inc.$01新建仓
20CITIGROUP INC$01减持

来源:SEC 13F 申报文件 · 截至 2026-06-30